Drug Discovery

The Icahn School of Medicine at Mount Sinai is pioneering AI-driven drug discovery through its new AI Small Molecule Drug Discovery Center. Machine learning and data science accelerate drug development by identifying therapeutic targets swiftly and accurately. The center focuses on crafting